Rare diseases cause 35% of deaths in the first year of life and 30% of deaths of children before their 5th birthday of those that survive. We try to leave no patient behind. Our mission is to cure the incurable.
RareAI’s process is designed to provide users with personalized analysis results based on their unique genetic profile and help them make informed decisions about their health and treatment options. It is important to note that all genetic information is kept confidential and de-identified to ensure privacy.
User uploads a de-identified genetic report containing pathological gene variance information to RareAI computational engine.
RareAI computational engine applies its machine learning algorithms to analyze the genetic report and compute potential diagnosis and treatment options based on the information present in the report.
Once the analysis is complete, the user receives an email containing a personalized gene analysis report that provides detailed information on the analysis results along with potential diagnosis and treatment options that can be explored.
The gene analysis report will also include personalized medicine options such as mRNA therapy that can be considered by the user based on their genetic makeup, which can assist healthcare professionals in tailoring treatment to the patient.